Cargando…

Cardiac involvement in patients with Spinal Muscular Atrophies

The spinal muscular atrophies (SMAs) include a group of disorders characterized by progressive weakness of the lower motor neurons. Several types of SMAs have been described based on age onset of clinical features: Acute infantile (SMA type I), chronic infantile (SMA type II), chronic juvenile (SMA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palladino, Alberto, Passamano, Luigia, Taglia, Antonella, D'Ambrosio, Paola, Scutifero, Marianna, Rosaria Cecio, Maria, Picillo, Esther, Viggiano, Emanuela, Torre, Vito, De Luca, Francesco, Nigro, Giovanni, Politano, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2011
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298107/ https://www.ncbi.nlm.nih.gov/pubmed/22616198

Ejemplares similares

Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients
por: PASSAMANO, LUIGIA, et al.
Publicado: (2012)

Genetic counseling in Pompe disease
por: Taglia, Antonella, et al.
Publicado: (2011)

Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene
por: TAGLIA, ANTONELLA, et al.
Publicado: (2015)

Xp21 contiguous gene deletion syndrome presenting as Duchenne muscular dystrophy and glycerol kinase deficiency associated with intellectual disability: case report and review literature
por: Pizza, Antonella, et al.
Publicado: (2023)

Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy
por: Viggiano, Emanuela, et al.
Publicado: (2023)

Autosomal dominant Ullrich congenital muscular dystrophy due to a de novo mutation in COL6A3 gene. A case report
por: Picillo, Esther, et al.
Publicado: (2022)

CLCN1 Molecular Characterization in 19 South-Italian Patients With Dominant and Recessive Type of Myotonia Congenita
por: Orsini, Chiara, et al.
Publicado: (2020)

Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms
por: Palladino, Alberto, et al.
Publicado: (2016)

The Role of TRPM4 Gene Mutations in Causing Familial Progressive Cardiac Conduction Disease: A Further Contribution
por: Palladino, Alberto, et al.
Publicado: (2022)

On a case of respiratory failure due to diaphragmatic paralysis and dilated cardiomyopathy in a patient with nemaline myopathy
por: TAGLIA, ANTONELLA, et al.
Publicado: (2012)

P-6 Unusual concurrence of Facio-scapulo-humeral dystrophy and Williams Syndrome in a young boy
por: Cecio, M.R., et al.
Publicado: (2011)

Bi-Allelic DES Gene Variants Causing Autosomal Recessive Myofibrillar Myopathies Affecting Both Skeletal Muscles and Cardiac Function
por: Onore, Maria Elena, et al.
Publicado: (2022)

Novel mutations in LMNA A/C gene and associated phenotypes
por: Petillo, Roberta, et al.
Publicado: (2015)

X-Linked Emery–Dreifuss Muscular Dystrophy: Study Of X-Chromosome Inactivation and Its Relation with Clinical Phenotypes in Female Carriers
por: Viggiano, Emanuela, et al.
Publicado: (2019)

Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up
por: Dori, Amir, et al.
Publicado: (2021)

Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up
por: Dori, Amir, et al.
Publicado: (2022)

P-12 Becker patients with isolated deletion of exon 48 in dystrophin gene present with a mild phenotype and seem to escape cardiomyopathy
por: Taglia, A., et al.
Publicado: (2011)

Gender effect on onset, prevalence and surgical treatment of cataract in patients with Myotonic Dystrophy type 1
por: Scutifero, Marianna, et al.
Publicado: (2022)

Cardiac diseases as a predictor warning of hereditary muscle diseases. The case of laminopathies
por: D’AMBROSIO, PAOLA, et al.
Publicado: (2019)

Deletion of the Williams Beuren syndrome critical region unmasks facioscapulohumeral muscular dystrophy
por: Rodolico, Carmelo, et al.
Publicado: (2020)

Magnetic resonance imaging in muscular dystrophies
por: Politano, Luisa, et al.
Publicado: (2015)

Therapeutic approach with Ataluren in Duchenne symptomatic carriers with nonsense mutations in dystrophin gene. Results of a 9-month follow-up in a case report
por: D’AMBROSIO, PAOLA, et al.
Publicado: (2018)

X Chromosome Inactivation in Carriers of Fabry Disease: Review and Meta-Analysis
por: Viggiano, Emanuela, et al.
Publicado: (2021)

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015)

Efficacy and safety of ropivacaine HCl in peribulbar anaesthesia for cataract surgery in patients with myotonic dystrophy type 1
por: Palladino, Alberto, et al.
Publicado: (2020)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population
por: Russo, Vincenzo, et al.
Publicado: (2016)

Scoliosis in Spinal Muscular Atrophy Type 1 in the Nusinersen Era
por: Al Amrani, Fatima, et al.
Publicado: (2022)

Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders
por: Jablonka, Sibylle, et al.
Publicado: (2022)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey
por: Coratti, Giorgia, et al.
Publicado: (2023)

Cross‐sectional serum metabolomic study of multiple forms of muscular dystrophy
por: Spitali, Pietro, et al.
Publicado: (2018)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2gd7cfhm5nstj1dtcsfplco4cb